Skip to content
OpenCapital
Get started

Baxter International BAX Fair Value Measurement Disclosure

Fair Value Measurement Disclosure at other companies

Medtronic logo
MedtronicMDT
——
Viatris logo
ViatrisVTRS
——

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$10.27B-50.6%
Enterprise value$8.48B-55.6%
P/S0.9×-1.0×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%—
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0×0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:DerivativeFairValueOfDerivativeLiability.

The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's fair value measurement disclosure.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Baxter International's fair value measurement disclosure?
Baxter International (BAX) reported fair value measurement disclosure of $2M in Q1 2026.
How has Baxter International's fair value measurement disclosure changed year-over-year?
Baxter International's fair value measurement disclosure decreased by 33.3% year-over-year, from $3M to $2M.
What is the long-term trend for Baxter International's fair value measurement disclosure?
Over 5 years (2020 to 2025), Baxter International's fair value measurement disclosure has grown at a -44.5% compound annual growth rate (CAGR), from $19M to $1M.